| Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 … C Allemani, T Matsuda, V Di Carlo, R Harewood, M Matz, M Nikšić, ... The Lancet 391 (10125), 1023-1075, 2018 | 4390 | 2018 |
| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1702 | 2019 |
| Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1306 | 2017 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1268-1283. e6, 2018 | 576 | 2018 |
| Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study G Gatta, L Botta, MJ Sánchez, LA Anderson, D Pierannunzio, L Licitra, ... European journal of cancer 51 (15), 2130-2143, 2015 | 516 | 2015 |
| Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT) FT Martin, RM Dwyer, J Kelly, S Khan, JM Murphy, C Curran, N Miller, ... Breast cancer research and treatment 124, 317-326, 2010 | 354 | 2010 |
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 351 | 2017 |
| Survival of women with cancers of breast and genital organs in Europe 1999–2007: results of the EUROCARE-5 study M Sant, MDC Lopez, R Agresti, MJS Pérez, B Holleczek, ... European journal of cancer 51 (15), 2191-2205, 2015 | 329 | 2015 |
| Mortality of emergency abdominal surgery in high-, middle-and low-income countries Journal of British Surgery 103 (8), 971-988, 2016 | 299 | 2016 |
| Photo-astrometric distances, extinctions, and astrophysical parameters for Gaia DR2 stars brighter than G= 18 F Anders, A Khalatyan, C Chiappini, AB Queiroz, BX Santiago, C Jordi, ... Astronomy & Astrophysics 628, A94, 2019 | 280 | 2019 |
| Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 271 | 2019 |
| 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence S Vaccarella, S Franceschi, G Engholm, S Lönnberg, S Khan, F Bray British journal of cancer 111 (5), 965-969, 2014 | 254 | 2014 |
| Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children … A Bonaventure, R Harewood, CA Stiller, G Gatta, J Clavel, DC Stefan, ... The Lancet Haematology 4 (5), e202-e217, 2017 | 212 | 2017 |
| Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240, 2017 | 191 | 2017 |
| Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: results from EUROCARE-5 LA Anderson, A Tavilla, H Brenner, S Luttmann, C Navarro, AT Gavin, ... European Journal of Cancer 51 (15), 2144-2157, 2015 | 187 | 2015 |
| Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379 KP O’brien, S Khan, KE Gilligan, H Zafar, P Lalor, C Glynn, C O’flatharta, ... Oncogene 37 (16), 2137-2149, 2018 | 179 | 2018 |
| Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: results of EUROCARE-5 C Lepage, R Capocaccia, M Hackl, V Lemmens, E Molina, ... European Journal of Cancer 51 (15), 2169-2178, 2015 | 158 | 2015 |
| Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 AM Dunning, K Michailidou, KB Kuchenbaecker, D Thompson, JD French, ... Nature genetics 48 (4), 374-386, 2016 | 153 | 2016 |
| On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007–results from the EUROCARE-5 study B Holleczek, S Rossi, A Domenic, K Innos, P Minicozzi, S Francisci, ... European Journal of Cancer 51 (15), 2158-2168, 2015 | 153 | 2015 |
| Advances in mesenchymal stem cell-mediated gene therapy for cancer RM Dwyer, S Khan, FP Barry, T O'Brien, MJ Kerin Stem cell research & therapy 1, 1-7, 2010 | 147 | 2010 |
